Abstract
Breast cancer is a heterogeneous disease and can be divided into subtypes, according to the immunophenotypic and gene expression profile. Patients undergoing neoadjuvant chemotherapy present different degrees of tumor response, ranging from no response to complete response. In addition to already established clinicopathological characteristics, such as staging, systemic inflammation can a…